Prenatal Intravenous Iron and Child Growth

Compared with standard-of-care (SOC) oral iron, does intravenous ferric carboxymaltose (FCM) treatment for pregnant women with anemia enhance postnatal child growth?In this secondary analysis of a randomized clinical trial with 738 infants in southern Malawi, there was no evidence of a difference in infants’ length for age, weight for age, or weight for length between the 2 groups.Compared with SOC, FCM treatment was not associated with substantial benefits on infant growth in southern Malawi.

Corresponding Author: Glory Mzembe, MSc, Training and Research Unit of Excellence (TRUE), 1 Kufa Rd, Post Office Box 30538, Blantyre, Malawi (gmzembe@cartafrica.org).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.